HAART-associated body habitus and metabolic changes, Part 1.
Liss
M
M
Department of International Medicine and Infectious Disease, New York Presbyterian Hospital-Weill Medical College of Cornell University, USA.
Boyle
B A
BA
D000273:Adipose Tissue / Q000187:drug effects; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001823:Body Composition / Q000187:drug effects; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008060:Lipodystrophy / Q000209:etiology*; D011480:Protease Inhibitors / Q000009:adverse effects; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects; D013577:Syndrome
D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors